The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.

The president who ran on his business acumen isn’t holding back in telling corporate bosses how to run their companies—or when to resign.

The Genomic Biomarkers Market represents a rapidly evolving segment within the global healthcare and biotechnology industries ...

A new market analysis projects the global myelodysplastic syndrome (MDS) treatment market will grow from an estimated value ...

The outgoing CEO’s final financial update highlighted the key issues facing his successor come their September 1 handover, ...

With autonomy from its former parent, we think Sandoz can freely allocate resources to fit its best needs and grow the business. Sandoz is one of the largest biosimilars players in the world, and we ...

Lilly's orforglipron led to 12.4% weight loss after 72 weeks while Novo Nordisk’s oral GLP-1RA showed a 13.6% drop in weight.

The omnipresence of medical misinformation has fundamentally changed how certain portions of the general public approach ...

Novo Nordisk will advance its acquired ATTR amyloidosis with cardiomyopathy monoclonal antibody (mAb) to Phase III trials. The Danish pharma said that the Phase II trial of coramitug (PRX004), an mAb ...

The demand for treatments targeting myeloproliferative disorders is rising sharply, propelled by several key factors that underscore the market's rob ...

Discover key insights from Arvinas, Inc.'s Q2 2025 earnings call, including CEO transition, clinical milestones, Pfizer partnership updates, and ...

Robert F. Kennedy Jr halted 22 mRNA vaccine initiatives, drawing criticism from health experts over pandemic preparedness ...